U
Imagion Biosystems Limited IBXXF
$0.01 -$0.025-71.43%
Recommendation
--
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
E
Sell 5/31/2024Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 5/31/2024 due to a decline in the volatility index and growth index.
D
Sell 4/25/2024Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 4/25/2024 due to an increase in the volatility index.
E
Sell 3/20/2024Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 3/20/2024 due to a decline in the total return index and volatility index.
D
Sell 9/5/2023Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 9/5/2023 due to an increase in the growth index, total return index and valuation index. Operating cash flow increased 2.27% from -$2.06M to -$2.01M, and EBIT increased 2.27% from -$2.47M to -$2.41M.
E
Sell 4/13/2023Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 4/13/2023 due to a decline in the total return index, valuation index and solvency index.
D
Sell 3/29/2023Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 3/29/2023 due to an increase in the valuation index.
E
Sell 3/14/2023Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell 2/21/2023Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 2/21/2023 due to an increase in the volatility index.
E
Sell 2/6/2023Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 2/6/2023 due to a decline in the valuation index and volatility index.
D
Sell 1/20/2023Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 1/20/2023 due to an increase in the valuation index and volatility index.
E
Sell 1/5/2023Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D- on 1/5/2023 due to a decline in the valuation index.
D
Sell 12/14/2022Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E+ on 12/14/2022 due to an increase in the valuation index and total return index.
E
Sell 8/26/2022Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D on 8/26/2022 due to a significant decline in the total return index, growth index and solvency index. Debt to equity increased from 0.13 to 0.14, and total revenue declined 1.35% from $96.3 to $95.
D
Sell 11/9/2021Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell 11/8/2021Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
D
Sell 10/1/2021Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D from D- on 10/1/2021 due to an increase in the valuation index and solvency index.
D
Sell 6/1/2021Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to D- from E on 6/1/2021 due to an increase in the total return index and valuation index.
E
Sell 4/14/2021Downgrade
Imagion Biosystems Limited (IBXXF) was downgraded to E from E+ on 4/14/2021 due to a substantial decline in the volatility index and total return index.
E
Sell 3/1/2021Upgraded
Imagion Biosystems Limited (IBXXF) was upgraded to E+ from E on 3/1/2021 due to a substantial increase in the total return index, solvency index and valuation index.
E
Sell 12/14/2020None
Imagion Biosystems Limited (IBXXF) was downgraded to E from U on 12/14/2020.
Weiss Ratings